TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+24.56%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$188M
AUM Growth
+$188M
(+3.1%)
Cap. Flow
-$34.7M
Cap. Flow
% of AUM
-18.46%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
2
Reduced
–
Closed
2
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$4.4M |
| 2 |
Phio Pharmaceuticals
PHIO
|
$1.13M |
| 3 |
Achieve Life Sciences
ACHV
|
$566K |
Top Sells
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$34.5M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$6.32M |
Sector Composition
| 1 | Healthcare | 78.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Heron Therapeutics
HRTX
$207M
| $71.6M | 38.07% |
4,919,625
| – | – |
|
|
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $39.2M | 20.87% |
2,144,387
| – | – |
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $22.7M | 12.08% |
182,300
| – | – |
|
|
MRTX
4
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $11.4M | 6.06% |
388,543
+150,111
| +63% | +$4.4M |
|
|
5
Achieve Life Sciences
ACHV
$152M
| $1.35M | 0.72% |
628,400
+263,400
| +72% | +$566K |
|
|
6
Phio Pharmaceuticals
PHIO
$11.3M
| $1.13M | 0.6% |
+1,572,699
| New | +$1.13M |
|
|
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-490,000
| Closed | -$6.32M |
|
|
SLXP
8
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| – | – |
-300,000
| Closed | -$34.5M |
|